Insider · CIK 0002057918
Benjamin Machinas Beneski
Files at ALLO (Allogene Therapeutics, Inc.). First filing Mar 18, 2025, latest Nov 19, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ALLO: Allogene Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | ALLOsell Allogene Therapeutics, Inc. | $959 786 shares | -0% | +29% from low-57% from high | |
| 23Weak | Allogene Therapeutics, Inc. | $11k 5,488 shares | -2% | +39% from low-40% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | ALLO Allogene Therapeutics, Inc. | SOpen-market sale Common Stock | -786 | $1.22 | $959 | 217,721 | Nov 19, 2025 |
| Mar 14, 2025 | ALLO Allogene Therapeutics, Inc. | SOpen-market sale Common Stock | -5,488 | $1.98 | $11k | 218,507 | Mar 18, 2025 |
| Mar 1, 2025 | ALLO Allogene Therapeutics, Inc. | AGrant or award Common Stock | +31,755 | $0.00 | $0 | 223,995 | Mar 5, 2025 |
| Mar 1, 2025 | ALLO Allogene Therapeutics, Inc. | AGrant or award Stock Option (Right to buy)derivative | +112,339 | $0.00 | $0 | 112,339 | Mar 5, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.